XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 9.08%187.44B | 10.99%47.7B | 10.48%48.76B | 7.20%47.97B | 7.58%43.01B | 9.64%171.84B | -0.30%42.98B | 5.35%44.13B | 25.13%44.75B | 11.13%39.99B |
Operating revenue | 9.08%187.44B | 10.99%47.7B | 10.48%48.76B | 7.20%47.97B | 7.58%43.01B | 9.64%171.84B | -0.30%42.98B | 5.35%44.13B | 25.13%44.75B | 11.13%39.99B |
Cost of revenue | 7.42%164.04B | 8.02%42.85B | 9.25%42.36B | 5.90%41.72B | 6.43%37.1B | 12.49%152.7B | 6.91%39.67B | 7.65%38.78B | 25.68%39.4B | 11.45%34.86B |
Gross profit | 22.30%23.41B | 46.60%4.85B | 19.42%6.4B | 16.78%6.24B | 15.33%5.91B | -8.78%19.14B | -44.88%3.31B | -8.73%5.36B | 21.27%5.35B | 9.06%5.13B |
Operating expense | 7.94%10.62B | 39.23%3.33B | 17.11%2.75B | -7.27%2.37B | -14.61%2.18B | -7.75%9.84B | -29.53%2.39B | -5.37%2.34B | 11.56%2.56B | 1.72%2.55B |
Selling and administrative expenses | 7.94%10.62B | 39.23%3.33B | 17.11%2.75B | -7.27%2.37B | -14.61%2.18B | -7.75%9.84B | -29.53%2.39B | -5.37%2.34B | 11.56%2.56B | 1.72%2.55B |
Operating profit | 37.49%12.78B | 65.80%1.52B | 21.22%3.65B | 38.83%3.87B | 44.90%3.74B | -9.85%9.3B | -64.83%918M | -11.18%3.01B | 31.81%2.79B | 17.44%2.58B |
Net non-operating interest income expense | -38.89%121M | 98.80%-4M | -16.07%188M | -210.61%-146M | -52.57%83M | 137.57%198M | 72.74%-332M | -33.92%224M | 116.39%132M | -39.86%175M |
Non-operating interest income | -12.80%967M | 291.82%211M | -13.02%394M | -83.24%60M | -26.16%302M | 141.09%1.11B | 88.42%-110M | -24.25%453M | 21.36%358M | -20.89%409M |
Non-operating interest expense | -7.14%846M | -3.15%215M | -10.04%206M | -8.85%206M | -6.41%219M | -7.70%911M | -17.16%222M | -11.58%229M | -3.42%226M | 3.54%234M |
Other net income (expense) | -583.04%-4.39B | -839.56%-4.08B | -153.74%-122M | -177.78%-84M | -600.00%-105M | -49.81%908M | -53.85%551M | -38.15%227M | 340.00%108M | -92.81%21M |
Gain on sale of security | -192.21%-225M | ---- | ---- | ---- | ---- | 67.37%-77M | ---- | ---- | ---- | ---- |
Earnings from equity interest | -1,073.96%-4.68B | -3,647.97%-4.36B | -153.74%-122M | -177.78%-84M | -600.00%-105M | -42.65%480M | -44.59%123M | -38.15%227M | 340.00%108M | -92.81%21M |
Other non- operating income (expenses) | 1.78%514M | ---- | ---- | ---- | ---- | -58.20%505M | ---- | ---- | ---- | ---- |
Income before tax | -18.11%8.52B | -325.09%-2.56B | 7.30%3.72B | 20.27%3.64B | 33.87%3.72B | -10.30%10.4B | -56.11%1.14B | -15.45%3.46B | 42.07%3.03B | -0.14%2.78B |
Income tax | 354.00%2.56B | 137.06%318M | 50.85%709M | 46.93%767M | 78.04%762M | -70.18%563M | -247.93%-858M | -44.38%470M | 6.53%522M | 1,628.57%428M |
Net income | -39.40%5.96B | -244.13%-2.87B | 0.47%3.01B | 14.76%2.88B | 25.87%2.95B | 1.36%9.84B | -0.65%1.99B | -7.93%2.99B | 52.68%2.51B | -16.42%2.35B |
Net income continuous Operations | -39.40%5.96B | -244.13%-2.87B | 0.47%3.01B | 14.76%2.88B | 25.87%2.95B | 1.36%9.84B | -0.65%1.99B | -7.93%2.99B | 52.68%2.51B | -16.42%2.35B |
Minority interest income | 84.32%-45M | 180.56%87M | 31.43%-48M | 3.39%-57M | 44.90%-27M | -26.99%-287M | -1,450.00%-108M | -32.08%-70M | -18.00%-59M | 62.60%-49M |
Net income attributable to the parent company | -40.67%6.01B | -240.93%-2.96B | -0.26%3.06B | 14.30%2.93B | 24.43%2.98B | 1.94%10.13B | 5.10%2.1B | -7.29%3.06B | 51.65%2.57B | -18.51%2.4B |
Preferred stock dividends | -1,214.15%-1.18B | -4,853.85%-1.24B | 3.85%27M | -44.44%15M | -66.67%9M | -89.60%106M | 73.33%26M | 0.00%26M | 3.85%27M | -97.16%27M |
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -28.27%7.19B | -183.09%-1.73B | -0.30%3.03B | 14.92%2.92B | 25.37%2.97B | 12.42%10.02B | 4.64%2.08B | -7.32%3.04B | 52.46%2.54B | 19.22%2.37B |
Basic earnings per share | -12.24%6.45 | -186.96%-1.4 | 22.62%2.71 | 40.44%2.57 | 51.18%2.57 | 19.12%7.35 | 14.18%1.61 | -2.21%2.21 | 60.53%1.83 | 25.00%1.7 |
Diluted earnings per share | -12.98%6.37 | -187.50%-1.4 | 21.82%2.68 | 39.34%2.55 | 51.48%2.56 | 19.41%7.32 | 14.29%1.6 | -2.22%2.2 | 60.53%1.83 | 25.19%1.69 |
Dividend per share | 33.33%0.48 | 33.33%0.12 | 33.33%0.12 | 33.33%0.12 | 33.33%0.12 | 100.00%0.36 | 0.00%0.09 | 0.00%0.09 | 0.09 | 0.09 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |